Tudor Investment Corp’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-119,834
| Closed | -$38M | – | 3455 |
|
|
2025
Q3 | $33.8M | Buy |
119,834
+62,743
| +110% | +$18.2M | 0.06% | 261 |
|
|
2025
Q2 | $15.9M | Buy |
57,091
+6,736
| +13% | +$1.91M | 0.03% | 433 |
|
|
2025
Q1 | $15.7M | Sell |
50,355
-8,814
| -15% | -$2.6M | 0.05% | 287 |
|
|
2024
Q4 | $15.4M | Buy |
+59,169
| New | +$17.6M | 0.06% | 204 |
|
|
2024
Q2 | – | Sell |
-164,400
| Closed | -$48.3M | – | 2285 |
|
|
2024
Q1 | $46.7M | Buy |
+164,400
| New | +$48.1M | 0.3% | 33 |
|
|
2023
Q3 | – | Sell |
-18,616
| Closed | -$4.13M | – | 2250 |
|
|
2023
Q2 | $4.13M | Sell |
18,616
-78,777
| -81% | -$18.3M | 0.05% | 520 |
|
|
2023
Q1 | $23.5M | Buy |
+97,393
| New | +$23.9M | 0.36% | 20 |
|
|
2022
Q3 | – | Sell |
-11,779
| Closed | -$2.87M | – | 2278 |
|
|
2022
Q2 | $2.87M | Buy |
11,779
+7,160
| +155% | +$1.75M | 0.08% | 350 |
|
|
2022
Q1 | $1.12M | Buy |
+4,619
| New | +$1.06M | 0.03% | 849 |
|
|
2021
Q4 | – | Sell |
-4,491
| Closed | -$955K | – | 2345 |
|
|
2021
Q3 | $955K | Sell |
4,491
-1,371
| -23% | -$316K | 0.02% | 1192 |
|
|
2021
Q2 | $1.43M | Buy |
+5,862
| New | +$1.44M | 0.03% | 704 |
|
|
2020
Q3 | – | Sell |
-7,423
| Closed | -$1.75M | – | 1262 |
|
|
2020
Q2 | $1.75M | Sell |
7,423
-3,364
| -31% | -$768K | 0.09% | 294 |
|
|
2020
Q1 | $2.19M | Sell |
10,787
-507
| -4% | -$111K | 0.2% | 80 |
|
|
2019
Q4 | $2.72M | Buy |
+11,294
| New | +$2.49M | 0.12% | 193 |
|
|
2019
Q3 | – | Sell |
-2,279
| Closed | -$420K | – | 1070 |
|
|
2019
Q2 | $420K | Sell |
2,279
-36,014
| -94% | -$6.45M | 0.01% | 771 |
|
|
2019
Q1 | $7.28M | Buy |
+38,293
| New | +$7.31M | 0.3% | 55 |
|
|
2018
Q3 | – | Sell |
-16,497
| Closed | -$3.04M | – | 1071 |
|
|
2018
Q2 | $3.04M | Sell |
16,497
-8,757
| -35% | -$1.55M | 0.11% | 160 |
|
|
2018
Q1 | $4.3M | Buy |
25,254
+15,538
| +160% | +$2.85M | 0.14% | 58 |
|
|
2017
Q4 | $1.69M | Buy |
+9,716
| New | +$1.72M | 0.04% | 205 |
|
|
2017
Q2 | – | Sell |
-7,832
| Closed | -$1.28M | – | 1018 |
|
|
2017
Q1 | $1.28M | Buy |
7,832
+4,132
| +112% | +$687K | 0.04% | 290 |
|
|
2016
Q4 | $541K | Sell |
3,700
-17,633
| -83% | -$2.65M | 0.01% | 678 |
|
|
2016
Q3 | $3.56M | Buy |
21,333
+15,664
| +276% | +$2.65M | 0.08% | 146 |
|
|
2016
Q2 | $863K | Buy |
5,669
+369
| +7% | +$57.4K | 0.02% | 520 |
|
|
2016
Q1 | $795K | Sell |
5,300
-2,729
| -34% | -$405K | 0.02% | 651 |
|
|
2015
Q4 | $1.3M | Buy |
8,029
+1,229
| +18% | +$193K | 0.04% | 344 |
|
|
2015
Q3 | $941K | Sell |
6,800
-1,175
| -15% | -$185K | 0.03% | 410 |
|
|
2015
Q2 | $1.22M | Sell |
7,975
-1,890
| -19% | -$303K | 0.04% | 338 |
|
|
2015
Q1 | $1.58M | Buy |
9,865
+5,265
| +114% | +$829K | 0.05% | 221 |
|
|
2014
Q4 | $733K | Buy |
4,600
+1,300
| +39% | +$203K | 0.03% | 505 |
|
|
2014
Q3 | $464K | Sell |
3,300
-5,713
| -63% | -$746K | 0.02% | 725 |
|
|
2014
Q2 | $1.07M | Buy |
9,013
+5,028
| +126% | +$582K | 0.04% | 186 |
|
|
2014
Q1 | $492K | Sell |
3,985
-3,712
| -48% | -$450K | 0.02% | 536 |
|
|
2013
Q4 | $878K | Buy |
+7,697
| New | +$876K | 0.04% | 250 |
|
|
2013
Q3 | – | Sell |
-6,300
| Closed | -$622K | – | 795 |
|
|
2013
Q2 | $622K | Buy |
+6,300
| New | +$654K | 0.05% | 237 |
|
Other funds holding AMGN
VCM
VPM
Tudor Investment Corp's AMGN Position: Q4 2025 in Review
Tudor Investment Corp sold out of Amgen (AMGN) in Q4 2025, closing a stake of 119,834 shares — an estimated $38M sold.
Tudor Investment Corp first reported a position in AMGN in Q2 2013 and held it in 34 quarters. The position peaked at $46.7M in Q1 2024. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.
- Tudor Investment Corp reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
- Tudor Investment Corp sold 119,834 Amgen shares in Q4 2025, an estimated $38M.
- Tudor Investment Corp first reported a position in Amgen in Q2 2013 and held it in 34 quarters.
- Tudor Investment Corp's Amgen position peaked at $46.7M in Q1 2024.
- 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.
Based on Tudor Investment Corp's 13F filing for Q4 2025, filed 17 Feb 2026.